20-02-36 BB. Medical Management of Endometriosis

23rd Annual Premier Women's Healthcare Virtual Conference

1.25 CE, 1.25 Rx (NCC 4)

Individuals who did not register for the Conference can now purchase individual session recordings. Anyone who was registered for the Main Conference (October 16-17, 2020) will have access to all recordings, free of any additional charge, through November 15, 2021.

 

Faculty:

Heidi Collins Fantasia PhD, RN, WHNP-BC

Associate Professor and Department Chair

Solomont School of Nursing at the University of Massachusetts Lowell

Lowell, Massachusetts  

Intended Audience:

Women’s Health Nurse Practitioners (WHNPs), WHNP students, Certified Nurse Midwives (CNMs) and other nurse practitioners and advanced practice clinicians who care for women.

 Activity Number:  20-02-36

 CE Approval Period:  Now through November 15, 2021

 Approved CE Credit Hours:  1.25 CE contact hour credits, 1.25 hours pharmacology credit  

Accreditation Statement:

This activity has been evaluated and approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women’s Health for 1.25 CE contact hours, 1.25 hours of pharmacology content. 

 Program Description

This session will focus on the medical management of endometriosis by the nurse practitioner. Many patients with a history of chronic pelvic pain have either a clinical or surgical diagnosis of endometriosis and will require management to control symptoms and preserve fertility. Common symptoms and clinical presentations of endometriosis will be discussed, as well as pharmacologic options.

 Educational Objectives:

At the conclusion of this activity, the learner will be able to:

  • Describe common symptoms of endometriosis
  • Describe 3 different pharmacologic approaches to endometriosis management
  • Discuss benefits and drawbacks of 3 different pharmacologic management strategies

 Faculty Disclosures:

Heidi Collins Fantasia PhD, RN, WHNP-BC has the following disclosures: Consultant Women’s Health Advisory Board and AbbVie Pharmaceuticals

 Successful Completion:

Successful completion of this activity requires the participant to:

  1. Read the educational objectives, disclosures and disclaimers.
  2. Watch the session recording
  3. Complete the session evaluation
  4. Print your CE certificate (the certificate will be stored on the NPWH E-Learning site under My Transcripts).
  5. These steps must be completed prior to the course expiration date
  6. Some courses required a post-test.  If a post test is required participants must earn a score of 70%.   

Therapeutic Disclosures:

Faculty members determine the content of the CE activity.  The content does not necessarily represent the views of NPWH.  Clinicians are responsible for evaluating information presented in relation to generally accepted standards of care and individual patient characteristics.

 Commercial Support: 

This activity has no commercial support

 You must be signed in to access this course.  You can sign in at the top right-hand corner of the page.

 **If you are an NPWH member, were once a member, or have completed CE activities with NPWH in the past, you have a username and password in the system.  Please DO NOT create a new account.  If you do not remember your username or password, please either click on the “forgot username” or “forgot password” link at the bottom of the sign on screen or call the NPWH office at (202) 543-9693 ext. 81

20-02-36 BB.  Medical Management of Endometriosis